XML 49 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INTANGIBLE ASSETS (Tables)
9 Months Ended
Jul. 31, 2017
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Schedule of indefinite-lived intangible assets
As of the dates indicated, other intangible assets are comprised of the following (in thousands):
 
July 31, 2017
 
October 31, 2016
 
Gross Intangible
 
Accumulated Amortization
 
Net Intangible
 
Gross
Intangible
 
Accumulated
Amortization
 
Net
Intangible
Developed technology
$
341,255

 
$
(262,308
)
 
$
78,947

 
$
347,727

 
$
(248,128
)
 
$
99,599

In-process research and development
671

 

 
671

 
4,200

 

 
4,200

Patents and licenses
7,165

 
(6,473
)
 
692

 
7,165

 
(6,285
)
 
880

Customer relationships, covenants not to compete, outstanding purchase orders and contracts
334,642

 
(307,962
)
 
26,680

 
358,647

 
(316,615
)
 
42,032

Total other intangible assets
$
683,733

 
$
(576,743
)
 
$
106,990

 
$
717,739

 
$
(571,028
)
 
$
146,711

Schedule of finite-lived intangible assets
As of the dates indicated, other intangible assets are comprised of the following (in thousands):
 
July 31, 2017
 
October 31, 2016
 
Gross Intangible
 
Accumulated Amortization
 
Net Intangible
 
Gross
Intangible
 
Accumulated
Amortization
 
Net
Intangible
Developed technology
$
341,255

 
$
(262,308
)
 
$
78,947

 
$
347,727

 
$
(248,128
)
 
$
99,599

In-process research and development
671

 

 
671

 
4,200

 

 
4,200

Patents and licenses
7,165

 
(6,473
)
 
692

 
7,165

 
(6,285
)
 
880

Customer relationships, covenants not to compete, outstanding purchase orders and contracts
334,642

 
(307,962
)
 
26,680

 
358,647

 
(316,615
)
 
42,032

Total other intangible assets
$
683,733

 
$
(576,743
)
 
$
106,990

 
$
717,739

 
$
(571,028
)
 
$
146,711

Expected future amortization of finite-lived intangible assets
Expected future amortization of intangible assets for the fiscal years indicated is as follows (in thousands):

Period ended October 31,
 
 
2017 (remaining three months)
$
5,993

 
2018
23,386

 
2019
22,839

 
2020
21,812

 
2021
18,878

 
Thereafter
13,411

 
 
$
106,319

(1) 

(1) Does not include amortization of in-process research and development, as estimation of the timing of future amortization expense would be impractical.